The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Autoreactive CD8 T cells associated with β cell destruction in type 1 diabetes
Open accessAbstract
Type 1 diabetes is a T cell-mediated autoimmune disease, and insulin is an important target of the autoimmune response associated with β cell destruction. The mechanism of destruction is still unknown. Here, we provide evidence for CD8 T cell autoreactivity associated with recurrent autoimmunity and loss of β cell function in type 1 diabetic islet transplant recipients. We first identified an insulin B chain peptide (insB10-18) with extraordinary binding affinity to HLA-A2(*0201) that is expressed by the majority of type 1 diabetes patients. We next demonstrated that this peptide is naturally processed by both constitutive and immuno proteasomes and translocated to the endoplasmic reticulum by the peptide transporter TAP1 to allow binding to HLA-A2 in the endoplasmic reticulum and cell surface presentation. Peripheral blood mononuclear cells from a healthy donor were primed in vitro with this peptide, and CD8 T cells were isolated that specifically recognize target cells expressing the insulin B chain peptide. HLA-A2 insB10-18 tetramer staining revealed a strong association between detection of autoreactive CD8 T cells and recurrent autoimmunity after islet transplantation and graft failure in type 1 diabetic patients. We demonstrate that CD8 T cell autoreactivity is associated with β cell destruction in type 1 diabetes in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phenotypic Analysis of Antigen-Specific T Lymphocytes
Altman, J. D., Moss, P. A. H., Goulder, P. J. R., Barouch, D. H., McHeyzer-Williams, M. G., Bell, J. I., McMichael, A. J., & Davis, M. M. (1996) · Science · doi:10.1126/science.274.5284.94 · Cited by 3,544
Characterization of Peptides Bound to the Class I MHC Molecule HLA-A2.1 by Mass Spectrometry
Hunt, D. F., Henderson, R. A., Shabanowitz, J., Sakaguchi, K., Michel, H., Sevilir, N., Cox, A. L., Appella, E., & Engelhard, V. H. (1992) · Science · doi:10.1126/science.1546328 · Cited by 1,198
Ohashi, P. S., Oehen, S., Buerki, K., Pircher, H., Ohashi, C. T., Odermatt, B., Malissen, B., Zinkernagel, R. M., & Hengartner, H. (1991) · Cell · doi:10.1016/0092-8674(91)90164-t · Cited by 1,173
Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice
Nakayama, M., Abiru, N., Moriyama, H., Babaya, N., Liu, E., Miao, D., Yu, L., Wegmann, D. R., Hutton, J. C., Elliott, J. F., et al. (2005) · Nature · doi:10.1038/nature03523 · Cited by 758
Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules
Ruppert, J., Sidney, J., Celis, E., Kubo, R. T., Grey, H. M., & Sette, A. (1993) · Cell · doi:10.1016/0092-8674(93)90472-3 · Cited by 628
Vozarova, B., Weyer, C., Lindsay, R. S., Pratley, R. E., Bogardus, C., & Tataranni, P. A. (2002) · Diabetes · doi:10.2337/diabetes.51.2.455 · Cited by 564
Zhang, J., Markovic-Plese, S., Lacet, B., Raus, J., Weiner, H. L., & Hafler, D. A. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.3.973 · Cited by 529
Arif, S., Tree, T. I., Astill, T. P., Tremble, J. M., Bishop, A. J., Dayan, C. M., Roep, B. O., & Peakman, M. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19585 · Cited by 479
Self-citationEndoplasmic Reticulum Stress and the Development of Diabetes
Harding, H. P., & Ron, D. (2002) · Diabetes · doi:10.2337/diabetes.51.2007.s455 · Cited by 465
The role of T-cells in the pathogenesis of Type 1 diabetes: From cause to cure
Roep, B. O. (2003) · Diabetologia · doi:10.1007/s00125-003-1089-5 · Cited by 431
Self-citationTian, J., Atkinson, M. A., Clare-Salzler, M., Herschenfeld, A., Forsthuber, T., Lehmann, P. V., & Kaufman, D. L. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.4.1561 · Cited by 426
Verge, C. F., Stenger, D., Bonifacio, E., Colman, P. G., Pilcher, C., Bingley, P. J., & Eisenbarth, G. S. (1998) · Diabetes · doi:10.2337/diabetes.47.12.1857 · Cited by 420
Kent, S. C., Chen, Y., Bregoli, L., Clemmings, S. M., Kenyon, N. S., Ricordi, C., Hering, B. J., & Hafler, D. A. (2005) · Nature · doi:10.1038/nature03625 · Cited by 409
Daniel, D., & Wegmann, D. R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.2.956 · Cited by 406
Elias, D., Reshef, T., Birk, O. S., van der Zee, R., Walker, M. D., & Cohen, I. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.8.3088 · Cited by 371
Daniel, D., Gill, R. G., Schloot, N., & Wegmann, D. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250430 · Cited by 358
Wong, F. S., Visintin, I., Wen, L., Flavell, R. A., & Janeway, C. A. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.1.67 · Cited by 346
Serreze, D. V., Leiter, E. H., Christianson, G. J., Greiner, D., & Roopenian, D. C. (1994) · Diabetes · doi:10.2337/diab.43.3.505 · Cited by 301
Insulin‐specific T cells are a predominant component of islet infiltrates in pre‐diabetic NOD mice
Wegmann, D. R., Norbury‐Glaseru, M., & Danielf, D. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240820 · Cited by 279
Kessler, J. H., Beekman, N. J., Bres-Vloemans, S. A., Verdijk, P., van Veelen, P. A., Kloosterman-Joosten, A. M., Vissers, D. C. J., ten Bosch, G. J. A., Kester, M. G. D., Sijts, A., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.1.73 · Cited by 263
Self-citationTian, J., Clere-Salzler, M., Herschenfeld, A., Middleton, B., Newman, D., Mueller, R., Arita, S., Evans, C., Atkinson, M. A., Mullen, Y., et al. (1996) · Nature Medicine · doi:10.1038/nm1296-1348 · Cited by 259
β2-Microglobulin–Deficient NOD Mice Do Not Develop Insulitis or Diabetes
Wicker, L. S., Leiter, E. H., Todd, J. A., Renjilian, R. J., Peterson, E., Fischer, P. A., Podolin, P. L., Zijlstra, M., Jaenisch, R., & Peterson, L. B. (1994) · Diabetes · doi:10.2337/diab.43.3.500 · Cited by 235
Autoreactive CD8 T Cells in Organ-Specific Autoimmunity
Liblau, R. S., Wong, F. S., Mars, L. T., & Santamaria, P. (2002) · Immunity · doi:10.1016/s1074-7613(02)00338-2 · Cited by 206
Reijonen, H., Novak, E. J., Kochik, S., Heninger, A., Liu, A. W., Kwok, W. W., & Nepom, G. T. (2002) · Diabetes · doi:10.2337/diabetes.51.5.1375 · Cited by 201
T-cell clones from a type-1 diabetes patient respond to insulin secretory granule proteins
Roep, B. O., Arden, S. D., de vries, R. R. P., & Hutton, J. C. (1990) · Nature · doi:10.1038/345632a0 · Cited by 185
Self-citationRoep, B. O., Stobbe, I., Duinkerken, G., van Rood, J. J., Lernmark, A., Keymeulen, B., Pipeleers, D., Claas, F. H., & de Vries, R. R. (1999) · Diabetes · doi:10.2337/diabetes.48.3.484 · Cited by 185
Self-citationDiLorenzo, T. P., Graser, R. T., Ono, T., Christianson, G. J., Chapman, H. D., Roopenian, D. C., Nathenson, S. G., & Serreze, D. V. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.21.12538 · Cited by 181
Tisch, R., Wang, B., & Serreze, D. V. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.3.1178 · Cited by 172
Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes.
Panina-Bordignon, P., Lang, R., van Endert, P. M., Benazzi, E., Felix, A. M., Pastore, R. M., Spinas, G. A., & Sinigaglia, F. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.5.1923 · Cited by 172
Distinct Proteolytic Processes Generate the C and N Termini of MHC Class I-Binding Peptides
Mo, X. Y., Cascio, P., Lemerise, K., Goldberg, A. L., & Rock, K. L. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.11.5851 · Cited by 161
Neisig, A., Roelse, J., Sijts, A. J. A. M., OSSENDORP, F. A., Feltkamp, M. C. W., Kast, W. M., Melief, C. J. M., & Neefjes, J. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.3.1273 · Cited by 157
Self-citationKeymeulen, B., Ling, Z., Gorus, F., et al. (1998) · Diabetologia · doi:10.1007/s001250050929 · Cited by 156
Self-citationBeekman, N. J. C. M., van Veelen, P. A., van Hall, T., Neisig, A., Sijts, A. J. A. M., Camps, M. G. M., Kloetzel, P., Neefjes, J., Melief, C. J. M., & OSSENDORP, F. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.4.1898 · Cited by 107
Self-citationMartinez, N. R., Augstein, P., Moustakas, A. K., Papadopoulos, G. K., Gregori, S., Adorini, L., Jackson, D. C., & Harrison, L. C. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17166 · Cited by 97
A gene in the HLA class I region contributes to susceptibility to IDDM in the Finnish population
Fennessy, M., Metcalfe, K., Hitman, G. A., Niven, M. J., Biro, P. A., Tuomilehto, J., Tuomilehto‐Wolf, E., & The Childhood Diabetes in Finland (DiMe) Study Group (1994) · Diabetologia · doi:10.1007/bf00400951 · Cited by 96
Identification of a β-Cell-Specific HLA Class I Restricted Epitope in Type 1 Diabetes
Panagiotopoulos, C., Qin, H., Tan, R., & Verchere, C. B. (2003) · Diabetes · doi:10.2337/diabetes.52.11.2647 · Cited by 96
van der Burg, S. H., Ras, E., Drijfhout, J. W., Benckhuijsen, W. E., Bremers, A. J. A., Melief, C. J. M., & Kast, W. M. (1995) · Human Immunology · doi:10.1016/0198-8859(95)00105-0 · Cited by 90
Self-citationSchloot, N. C., Roep, B. O., Wegmann, D. R., Yu, L., Chase, H. P., Wang, T., & Eisenbarth, G. S. (1997) · Diabetologia · doi:10.1007/s001250050716 · Cited by 78
Self-citationMarron, M. P., Graser, R. T., Chapman, H. D., & SERREZE, D. V. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.212221199 · Cited by 73
Identification of Children with Early Onset and High Incidence of Anti-islet Autoantibodies
Robles, D. T., Eisenbarth, G. S., Wang, T., Erlich, H. A., Bugawan, T. L., Babu, S. R., Barriga, K., Norris, J. M., Hoffman, M., KLINGENSMITH, G. J., et al. (2002) · Clinical Immunology · doi:10.1006/clim.2001.5171 · Cited by 55
Drijfhout, J. W., Brandt, R. M. P., D'Amaro, J., Kast, W. M., & Melief, C. J. M. (1995) · Human Immunology · doi:10.1016/0198-8859(94)00151-f · Cited by 42
Self-citationPrecursor frequencies of T-cells reactive to insulin in recent onset type 1 diabetes mellitus
Naik, R. G., Beckers, C., Wentwoord, R. A. R., Frenken, A., Duinkerken, G., Brooks‐Worrell, B., Schloot, N. C., Palmer, J. P., & Roep, B. O. (2004) · Journal of Autoimmunity · doi:10.1016/j.jaut.2004.04.002 · Cited by 28
Self-citation
Cited by
Type 1 Diabetes: Etiology, Immunology, and Therapeutic Strategies
Van Belle, T. L., Coppieters, K. T., & Von Herrath, M. G. (2011) · Physiological Reviews · doi:10.1152/physrev.00003.2010 · Cited by 1,022
Coppieters, K. T., Dotta, F., Amirian, N., Campbell, P. D., Kay, T. W. H., Atkinson, M. A., Roep, B. O., & von Herrath, M. G. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20111187 · Cited by 672
Self-citationType 1 diabetes mellitus as a disease of the β-cell (do not blame the immune system?)
Roep, B. O., Thomaidou, S., van Tienhoven, R., & Zaldumbide, A. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-00443-4 · Cited by 623
Self-citationLocalization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A
The Wellcome Trust Case Control Consortium, Nejentsev, S., Howson, J. M. M., Walker, N. M., Szeszko, J., Field, S. F., Stevens, H. E., Reynolds, P., Hardy, M., King, E., et al. (2007) · Nature · doi:10.1038/nature06406 · Cited by 570
Dotta, F., Censini, S., van Halteren, A. G. S., Marselli, L., Masini, M., Dionisi, S., Mosca, F., Boggi, U., Muda, A. O., Prato, S. D., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700442104 · Cited by 569
Self-citation
Metadata
- Authors
- Pinkse, G. G. M., Tysma, O. H. M., Bergen, C. A. M., Kester, M. G. D., Ossendorp, F., van Veelen, P. A., Keymeulen, B., Pipeleers, D., Drijfhout, J. W., & Roep, B. O.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2005-12-09
- Volume
- 102
- Issue
- 51
- Pages
- 18425-18430
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2071591384
- Cited by
- 276
- References
- 42
- FWCI
- 10.08
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.